Pharmaceutical Companies

Questions for Review 1. Pharmaceutical companies do collapse a debt instrument to distribute drugs for a low cost in developing and worthlesser countries. Africas GDP, and per capita income is very low so they cannot afford to buy top flavour medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very high-ticket(prenominal) to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that compensate make exceptions to IPR law for developing countries are national treatment that is fit of foreign and domestic nationals.Most-favored-nation treatment and the equal treatment of all WTO members. Also, technical progress. One last argument is how to provide nice protection for this, and enforcing it. The arguments by NGOs and others to relax IPR laws are to end trade pressure on poor countries in health care industry disputes. 3. I would expect southwestern Af ricas decision to levy duties on drug imports from western nations to have a prejudicious impact on the international distribution of drugs to second Africa. If it is already expensive and hard to get drugs to AIDS patients in Africa, making them more expensive will not help. .In my opinion, I feel handle this was an appropriate change of policy because it did lower prices on drugs. Some negative ramifications of this resolutions is that the price wouldnt drop low enough. 5. I do not think it was necessary to relax IPR rules in order to ensure that adequate supplies of AIDS medications would be available for distribution in the developing domain of a function because the US took initiative to fix high drug prices and low-quality health infrastructures. 6. MNCs have an ethical responsibility in providing funding to international organizations wish the global fund to help cure AIDS